Main Menu

NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

MedinCell S.A (PA: MEDCL)

 
MEDCL Technical Analysis
4
As on 26th Jan 2026 MEDCL STOCK Price closed @ 26.38 and we RECOMMEND Buy for LONG-TERM with Stoploss of 17.50 & Strong Buy for SHORT-TERM with Stoploss of 16.35 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

MEDCLSTOCK Price

Open 29.30 Change Price %
High 29.30 1 Day -2.82 -9.66
Low 26.38 1 Week -0.50 -1.86
Close 26.38 1 Month -1.12 -4.07
Volume 212533 1 Year 8.52 47.70
52 Week High 38.46 | 52 Week Low 12.84
 
PA France Most Active Stocks
ALBOO 0.00 %
FTI 5.91 -1.66%
ALADO 0.00 %
VIEDS 0.72 4.35%
ALNEV 0.00 %
AVT 0.06 %
CGG 0.69 -2.82%
ORA 15.22 1.60%
ALHYG 0.01 0.00%
ALNRG 0.00 %
 
PA France Top Gainers Stocks
ALREA 0.80 50.94%
ALDBT 0.04 33.33%
ALBIO 1.13 28.41%
HDP 2.04 19.30%
HDP 2.04 19.30%
NXI 9.77 18.28%
ALAGO 0.13 18.18%
FNAC 35.40 17.02%
ALRPD 5.00 14.94%
ALSGD 0.11 10.00%
 
PA France Top Losers Stocks
AKOM 4.06 -37.05%
AKOM 4.06 -37.05%
FPN 0.02 -33.33%
ALUCI 2.55 -27.14%
ALKAL 2.62 -26.82%
MLONL 0.73 -14.12%
ORP 7.90 -12.03%
MLMON 0.88 -12.00%
ALDBL 3.72 -10.14%
MEDCL 26.38 -9.66%
 
 
MEDCL
Daily Charts		 MEDCL
Intraday Charts		 Whats New @
Bazaartrend		 MEDCL
Free Analysis
 
MEDCL Important Levels Intraday
RESISTANCE32.01
RESISTANCE30.20
RESISTANCE29.09
RESISTANCE27.97
SUPPORT24.79
SUPPORT23.67
SUPPORT22.56
SUPPORT20.75
 
MEDCL Forecast January 2026
Share
4th UP Forecast35.05
3rd UP Forecast32.27
2nd UP Forecast30.55
1st UP Forecast28.83
1st DOWN Forecast23.93
2nd DOWN Forecast22.21
3rd DOWN Forecast20.49
4th DOWN Forecast17.71
 
MEDCL Weekly Forecast
4th UP Forecast29.73
3rd UP Forecast28.66
2nd UP Forecast27.99
1st UP Forecast27.33
1st DOWN Forecast25.43
2nd DOWN Forecast24.77
3rd DOWN Forecast24.10
4th DOWN Forecast23.03
 
MEDCL Forecast2026
4th UP Forecast79.72
3rd UP Forecast62.61
2nd UP Forecast52.04
1st UP Forecast41.47
1st DOWN Forecast11.29
2nd DOWN Forecast0.72
3rd DOWN Forecast-9.85
4th DOWN Forecast-26.96
 
 
MEDCL Other Details
Segment EQ
Market Capital 251922896.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
MEDCL Address
MEDCL
 
MEDCL Latest News
 
Your Comments and Response on MedinCell S.A
 
MEDCL Business Profile
MedinCell S.A. develops various therapeutic solutions. It develops solutions based on BEPO, a technology for long-acting injectable products based on proprietary copolymers and a biocompatible solvent, which solubilizes or suspends the active pharmaceutical ingredients. The company's products in development include mdc-IRM, a subcutaneous injection in Phase III trials for use in the treatment of schizophrenia; mdc-CWM, an intra-articular injection to treat pain and inflammation; and mdc-TJK, a subcutaneous injection in preclinical trials for use in the treatment of schizophrenia. Its product candidates in formulation research comprise subcutaneous injections, such as mdc-WWM for contraception; mdc-ANG for CNS related treatments; mdc-ELK for depression; and mdc-GRT for use in organ transplant, as well as perineural injections, including mdc-CMV for anesthesia and pain, and mdc-NVA for pain. The company is based in Jacou, France. Address: 3 rue des Frères Lumière, Jacou, France, 34830
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service